India's medicines become trouble-shooter for china suffering from Corona, black marketing is going on indiscriminately despite the ban

Broadly speaking, most people in china rely on Pfizer's Paxovid (nimtrelvir) and the Indian-made generic versions of azvudine, Primovir, Paxista, Molnunit and Molnatris, to treat Covid.

There is a ban on the sale and use of generic drugs made in india in China. But, in front of the uncontrollable situation of Kovid infection, the Chinese government is seen on its knees. Despite the restrictions, black marketing of generic medicines made in india is going on indiscriminately here and the government has given tacit consent for this. Apart from this, the National health Commission of china has announced the widespread distribution of Paxlovid of American company Pfizer for the treatment of Kovid. This is the first foreign drug, which is planned to be provided in government hospitals in China.

Broadly speaking, most people in china rely on Pfizer's Paxovid (nimtrelvir) and the Indian-made generic versions of azvudine, Primovir, Paxista, Molnunit and Molnatris, to treat Covid. Shahil Munjal, chairman of the Pharmaceuticals Export Promotion Council of india, said that the demand for covid and other medicines is continuously coming from China. The highest demand has been seen for ibuprofen and paracetamol.

china had stopped international flights for the last three years under the zero Covid policy. But, now that the peak phase of Kovid is going on there and very few cases of Kovid are being reported all over the world, china has announced to end all kinds of travel ban. Here, even the mandatory quarantine on arrival in china was abolished from Tuesday. Immediately after this announcement by the National health Commission, millions of Chinese people have started booking air tickets to travel abroad.

japan and south korea are particularly concerned about the lifting of travel restrictions, as these countries receive the most Chinese tourists. Soon after the Chinese government's decision, Japanese PM Fumio Kishida said that passengers coming from china to japan would compulsorily show the latest negative RTPCR report. Along with this, he said that the government has also instructed airlines to operate limited number of flights to China.

Due to doubt on the effect of Chinese vaccine, Thailand-Singapore has stopped the use of Chinese vaccine with immediate effect. At the same time, turkey has also decided to re-study the vaccine.

Vaccine buyers from china include turkey, Brazil, Indonesia, Pakistan, Bangladesh, Iran, Philippines, Morocco, Thailand, Argentina, Venezuela, Cambodia, Sri Lanka, chile and Mexico.

In sichuan province with a population of 83 million, more than 60 percent of the people have been infected. In the survey, 63 percent admitted that they have been infected in the last few days.